Back to Search Start Over

Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old

Authors :
Francesco Nicoli
Emmanuel Clave
Kerstin Wanke
Amrei von Braun
Vincent Bondet
Cécile Alanio
Corinne Douay
Margaux Baque
Claire Lependu
Peggy Marconi
Karin Stiasny
Franz X. Heinz
Margot Muetsch
Darragh Duffy
Jacques Boddaert
Delphine Sauce
Antoine Toubert
Urs Karrer
Victor Appay
Centre d'Immunologie et des Maladies Infectieuses (CIMI)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Università degli Studi di Ferrara = University of Ferrara (UniFE)
Ecotaxie, microenvironnement et développement lymphocytaire (EMily (UMR_S_1160 / U1160))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
University hospital of Zurich [Zurich]
Immunologie Translationnelle - Translational Immunology lab
Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité)
Immunité et cancer (U932)
Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institute of Virology (Vienna)
Medizinische Universität Wien = Medical University of Vienna
Hopital Saint-Louis [AP-HP] (AP-HP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Immunology from Concept and Experiments to Translation (ImmunoConcept)
Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)
Funding: This work was supported by the ANR (Project ANR-14-CE14-0030-01) and by Universita ItaloFrancese/Univeriste FrancoItalienne (Galileo Project G10-718
PHC Galilee Project 39582TJ), by the Swiss National Science Foundation (grant PP0033-110737 to UK), by the Heuberg Foundation (Zurich, Switzerland), by the AETAS Foundation (Geneva, Switzerland) and by a Senior IdEx Chair of the University of Bordeaux (France). EC, VB, CA, MA, DD and AT were supported by the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence 'Milieu Interieur' Grant ANR-10-LABX-69-01. EC and AT are supported by the Agence Nationale de la Recherche (Project RANKLthym ANR-19- CE18-0021-02).
ANR-19-CE18-0021,RANKLthym,Évaluer le potentiel de RANK ligand pour rétablir des fonctions thymiques efficaces après greffe de moelle osseuse et vieillissement(2019)
Kumamoto University
This work was supported by the ANR (Project ANR-14-CE14-0030-01) and by Università ItaloFrancese/Univeristé FrancoItalienne (Galileo Project G10-718
PHC Galilee Project 39582TJ), by the Swiss National Science Foundation (grant PP0033-110737 to UK), by the Heuberg Foundation (Zurich, Switzerland), by the AETAS Foundation (Geneva, Switzerland) and by a Senior IdEx Chair of the University of Bordeaux (France). EC, VB, CA, MA, DD and AT were supported by the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence 'Milieu Intérieur' Grant ANR-10-LABX-69-01. EC and AT are supported by the Agence Nationale de la Recherche (Project RANKLthym ANR-19- CE18-0021-02).
ANR-14-CE14-0030,PriCelAge,Induction de réponses cellulaires T avec l'âge avancé(2014)
ANR-10-LABX-0069,MILIEU INTERIEUR,GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE(2010)
HAL-SU, Gestionnaire
Appel à projets générique - Induction de réponses cellulaires T avec l'âge avancé - - PriCelAge2014 - ANR-14-CE14-0030 - Appel à projets générique - VALID
Laboratoires d'excellence - GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE - - MILIEU INTERIEUR2010 - ANR-10-LABX-0069 - LABX - VALID
Évaluer le potentiel de RANK ligand pour rétablir des fonctions thymiques efficaces après greffe de moelle osseuse et vieillissement - - RANKLthym2019 - ANR-19-CE18-0021 - AAPG2019 - VALID
Source :
EBioMedicine, EBioMedicine, 2022, 76, pp.103852. ⟨10.1016/j.ebiom.2022.103852⟩, EBioMedicine, Vol 76, Iss, Pp 103852-(2022)
Publication Year :
2022
Publisher :
HAL CCSD, 2022.

Abstract

Advanced age is accompanied by a decline of immune functions, which may play a role in increased vulnerability to emerging pathogens and low efficacy of primary vaccinations in elderly people. The capacity to mount immune responses against new antigens is particularly affected in this population. However, its precise determinants are not fully understood. We aimed here at establishing the influence of persistent viral infections on the naive T-cell compartment and primary immune responsiveness in older adults.We assessed immunological parameters, related to CD8We demonstrate a prevalent effect of age and CMV infection on CD8These data provide insights on the changes in adaptive immunity over time and the associated decline in vaccine efficacy with ageing. This knowledge is important for the management of emerging infectious diseases in elderly populations.This work was supported by the ANR (Project ANR-14-CE14-0030-01) and by Universita ItaloFrancese/Univeriste FrancoItalienne (Galileo Project G10-718; PHC Galilee Project 39582TJ), by the Swiss National Science Foundation (grant PP0033-110737 to UK), by the Heuberg Foundation (Zurich, Switzerland), by the AETAS Foundation (Geneva, Switzerland) and by a Senior IdEx Chair of the University of Bordeaux (France). EC, VB, CA, MA, DD and AT were supported by the French Government's Investissement d'Avenir Program, Laboratoire d'Excellence "Milieu Interieur" Grant ANR-10-LABX-69-01. EC and AT are supported by the Agence Nationale de la Recherche (Project RANKLthym ANR-19- CE18-0021-02).

Details

Language :
English
ISSN :
23523964
Database :
OpenAIRE
Journal :
EBioMedicine, EBioMedicine, 2022, 76, pp.103852. ⟨10.1016/j.ebiom.2022.103852⟩, EBioMedicine, Vol 76, Iss, Pp 103852-(2022)
Accession number :
edsair.doi.dedup.....24599d5bc7deb85d748a94fd9984b4e4
Full Text :
https://doi.org/10.1016/j.ebiom.2022.103852⟩